Explore the ethical considerations of anesthesia choice in Moyamoya disease as we delve into the pilot study comparing Propofol and Desflurane’s effects on patient outcomes.
– by Klaus
Note that Klaus is a Santa-like GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Propofol versus Desflurane in Moyamoya Disease Patients-A Pilot Study.
Ankolekar et al., Asian J Neurosurg 2023
DOI: 10.1055/s-0043-1775588
Ho-ho-ho! Gather ’round, my curious elves, for a tale of medical wonder in the frosty realm of neurosurgery. Our story begins in a workshop not of toys, but of science, where the cleverest of doctors pondered a Christmas conundrum: Objectives – should they gift their patients with moyamoya disease (MMD) the inhalational delight of desflurane or the intravenous charm of propofol during revascularization surgery? Their goal, as pure as the driven snow, was to compare the neurological outcomes of these two anesthetic agents.
With the blessing of the institutional ethics committee, much like Santa’s list of who’s naughty or nice, they embarked on a Materials and Methods journey. Patients with MMD were split into two groups, as if by Santa’s own hand, one to receive the merry mist of desflurane, the other the peaceful potion of propofol. The doctors then checked their lists twice, assessing neurological outcomes with the care of crafting toys, using the modified Rankin score (mRS) and the extended Glasgow outcome score (GOS-E).
They monitored the patients’ sleigh ride through surgery, noting hemodynamic parameters, end-tidal carbon dioxide, entropy, and the brain relaxation scores (BRS), as well as any rescue measures needed for brain relaxation. It was a list longer than Santa’s!
Then came the Statistical Analysis, where numbers danced like sugarplums to reveal truths through Kolmogorov-Smirnov tests, unpaired t-tests, Mann-Whitney U tests, and chi-squared tests. The Results were as eagerly anticipated as Christmas morning: 17 patients, 10 with desflurane and 7 with propofol, showed comparable mRS and GOS-E scores, as if the two anesthetics were twins in efficacy. However, the desflurane group needed more rescue measures, like a sleigh needing extra reindeer to take off.
Finally, the Conclusion was as clear as a star atop the Christmas tree: both desflurane and propofol were equally effective in postoperative neurological outcomes for MMD patients. Yet, propofol provided a superior surgical field, as calm and bright as a silent night. And so, the doctors learned that whether by inhalation or infusion, the gift of a successful surgery could be achieved. Merry outcomes to all, and to all a good recovery!